European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria

Annals of the Rheumatic Diseases

Volumn 62, Issue 9, 2003, Pages 901-903

  Valentini, G ^a   Bencivelli, W ^b   Bombardieri, S ^b   D'Angelo, S ^a   Della Rossa, A ^b   Silman, A J ^c   Black, C M ^d   Czirjak, L ^e   Nielsen, H ^f   Vlachoyiannopoulos, P G ^g  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF PÉCS   (Hungary)

^f GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^g UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DETERIORATION; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFUSE SYSTEMIC SCLEROSIS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LIMITED SYSTEMIC SLCEROSIS; SCLEREDEMA; SCLERODERMA; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; VALIDATION PROCESS; VASCULAR DISEASE;

HUMANS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX;

EID: 0042508746     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.9.901     Document Type: Article

References (11)

1. Della Rossa A, Valentini G, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. I. Clinical and epidemiological features of 290 patients from 19 centres. Ann Rheum Dis 2001;60:585-91.
2. Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of a preliminary activity index. Ann Rheum Dis 2001;60:592-8.
3. Shao J, Tu D. The jackknife and the bootstrap. New York: Springer, 1995.
4. Kahaleh MB, Sultany GL, Smith EA, Huffstutter JE, Loadholt CB, Le Roy EC. A modified scleroderma skin scoring method. Clin Exp Rheumatol 1986;4:367-9.
5. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
6. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, and the European Consensus Study Group for disease activity in SLE. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992;10:541-7.
7. Ward MM, Marx AS, Barry NN. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. J Rheumatol 2000;27:664-70.
8. Liang MH, Sucher SA, Roberts WN, Esdaile JM. Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum 1988;31:817-25.
9. Scott DL, Panayi GS, van Riel PL, Smolen J, van de Putte LB. Disease activity in rheumatoid arthritis: preliminary report of the Consensus Study Group of the European Workshop for Rheumatology Research. Clin Exp Rheumatol 1992;10:521-5.
10. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
11. Boers M, Tugwell P. OMERACT conference questionnaire results. OMERACT Committee. J Rheumatol 1993;20:552-4.